Healthcare Business

Valeant Pharmaceuticals Gets Boost From FDA Update

Shares of Valeant Pharmaceuticals International Inc. (NYSE: VRX) saw a handy gain on Thursday after the company provided an update from the U.S. Food and Drug Administration (FDA). Specifically, the ...
Read Full Story »

FibroGen Prices Follow-On Offering

Shares of FibroGen Inc. (NASDAQ: FGEN) saw a handy gain on Wednesday after the firm announced the pricing of its underwritten follow-on offering. The offering is expected to close by ...
Read Full Story »

Zai Lab Files for IPO

Zai Lab has registered an F-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, but ...
Read Full Story »

How Kala Pharmaceuticals Could Rise 100% to 200%

Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is a recent initial public offering that could come blessed with magical upside if its possibilities blossom into a positive reality. The company is targeting ...
Read Full Story »

Zynerba Midstage Cannabinoid Trial Falls Short

Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) saw its shares sink to a 52-week low after the firm announced results from its midstage trial evaluating ZYN002 (cannabidiol [CBD] gel) for the treatment ...
Read Full Story »

Major Biotechs Send Short Sellers Running for Cover

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Why Acadia Pharma Is One of Wednesday’s Best Earnings Reports

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) reported its second-quarter financial results after the markets closed on Tuesday. This company perhaps had one of the best responses to its earnings report on ...
Read Full Story »

Mylan Crashes to Multiyear Low on Missed Earnings

Mylan N.V. (NASDAQ: MYL) released its most recent quarterly earnings report before the markets opened on Wednesday. Unfortunately, the earnings and guidance weren't strong enough to hold up the firm ...
Read Full Story »

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Valeant Pharmaceuticals International Inc. (NYSE: VRX) reported its second-quarter financial results before the markets opened on Tuesday. This stock is known for its fall from grace, trading above $250 per ...
Read Full Story »

Why Fibrogen Shares Are Exploding

When FibroGen Inc. (NASDAQ: FGEN) released its most recent quarterly results after the markets closed on Monday, it was not the most important news that broke. The firm also updated ...
Read Full Story »

Jefferies Sees Big Upside From 4 Upcoming Near-Term Biotech Catalysts

If there is one area that can generate riches for speculative investors, it would have to be biotech and emerging pharma. After all, how many companies can go from nothing ...
Read Full Story »

Horizon Pharma Wins Big in Q2

Horizon Pharma PLC (NASDAQ: HZNP) released its most recent quarterly earnings report before the markets opened on Monday. The firm said that it had $0.41 in earnings per share (EPS) ...
Read Full Story »

Agile Therapeutics Tanks on Secondary Offering

Agile Therapeutics Inc. (NASDAQ: AGRX) saw its stock dip early on Thursday after the firm announced a secondary offering. Although the stock is down year to date, it’s actually more ...
Read Full Story »

Zealand Pharma Closes in on IPO

Zealand Pharma has filed an amended F-1 form with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO). The company intends to price its ...
Read Full Story »